Trials / Sponsors / Modus Therapeutics AB
Modus Therapeutics AB
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin Safety and Tolerability | Phase 1 | 2019-02-06 |
| Completed | Sevuparin Infusion for the Management of Acute VOC in Subjects With SCD Sickle-Cell Disease | Phase 2 | 2015-07-01 |
| Terminated | Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria Malaria, Falciparum | Phase 1 / Phase 2 | 2011-09-01 |